Cases and
webinars
Webinar “Highlights of the next-in-class drugs development”
The development of pharmacologically similar agents and improved analogues of innovative drugs (next-in-class) is one of the target directions in evolution of Russian pharmaceutical industry under the “Pharma 2020” program.
What will we discuss in Webinar?
-
the advantages and risks of next-in-class drug development
-
specifics of these drugs clinical trials program planning
-
the applicability of adaptive designs using in clinical trials of the next-in-class drug on the example of different pharmacological classes
For whom?
For drug developers, pharmaceutical and biotech companies, participants in the clinical trial market, doctors.
Hosts:
Natalia Vostokova, IPHARMA Chief Operating Officer
Julia Tahtenberg, IPHARMA Medical Director